Pricing Log in Create free account

Attovia Therapeutics, Inc. (ATTO) vs Lexicon Pharmaceuticals, Inc. (LXRX)

Attovia Therapeutics, Inc. and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Attovia Therapeutics, Inc. and Lexicon Pharmaceuticals, Inc. are of similar size ($716.4M and $684.8M). Across the 4 metrics below, Attovia Therapeutics, Inc. leads on 3 and Lexicon Pharmaceuticals, Inc. on 1.

Valuation

Metric ATTO LXRX Biotechnology median
P/E — n/m 10.60
P/S n/m 20.67 9.40
P/B n/m 4.86 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 17.38 9.02
Earnings yield — (8.05%) (32.88%)
Free cash flow yield 0.00% (6.31%) (23.13%)

Profitability

Metric ATTO LXRX Biotechnology median
Gross margin — 98.89% 68.51%
Operating margin — (147.42%) 0.00%
Net margin — (161.80%) 0.00%
Free cash flow margin — (127.76%) 0.00%
Return on equity — (43.91%) (51.96%)
Return on assets — (27.84%) (46.06%)
Return on invested capital 0.00% (109.13%) 0.00%

Growth

Metric ATTO LXRX Biotechnology median
Revenue growth (TTM) — (45.62%) 6.76%
EPS growth (last fiscal year) — 77.78% 29.88%
Revenue growth, 5-year CAGR — 15.72% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ATTO LXRX Biotechnology median
Debt to equity 0.00 0.32 0.00
Current ratio 9.39 10.63 4.97
Net debt to EBITDA — 0.91 1.01

Dividend

Metric ATTO LXRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATTO LXRX Biotechnology median
Market cap 684.77m 716.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack